Lupus News Today Home | Lupus News Today
2024年11月20日 · The Web's Daily Resource for Lupus News
Lupkynis for Lupus Nephritis - Lupus News Today
2023年1月30日 · What is Lupkynis for lupus nephritis? Lupkynis (voclosporin) is an oral therapy approved to treat lupus nephritis, a severe complication of lupus characterized by kidney …
1st patient enrolled in global Phase 2 trial of daxdilimab for...
2023年5月18日 · A Phase 2 trial evaluating the safety and efficacy of daxdilimab, a potentially first-in-class treatment for people with active, proliferative lupus nephritis (LN) — a lupus …
FDA updates Lupkynis label to include long-term efficacy data
2024年5月6日 · The data came from AURORA 2 (NCT03597464), a two-year extension to the one-year Phase 3 AURORA 1 trial (NCT03021499) that looked at how safe Lupkynis is and …
Lupkynis protects kidneys in lupus nephritis for up to 3 years
2023年7月24日 · That’s according to the full results from AURORA 2 (NCT03597464), a Phase 3 extension study that evaluated how safe and well tolerated Lupkynis is and how well it works …
1st lupus patient treated with CAR T-cell therapy FT819 in early trial
2024年5月16日 · A CAR T-cell approach targeting CD19 was recently validated in an academic investigator-sponsored study, which showed that all patients with lupus-related kidney …
Lupkynis approved in Japan to treat lupus nephritis
2024年10月3日 · Lupkynis is designed to lessen the inflammation that drives lupus nephritis, and to support the health and function of kidney cells. It works by blocking the activity of a specific …
Long-term safety of Lupkynis for SLE confirmed in AURORA trial
2023年4月10日 · New top-line data show participants in the Lupkynis treatment arm of the now completed Phase 3 AURORA trial (NCT03021499) had similar kidney biopsy (histologic) …
2 New Meds Found to Change Lupus Nephritis Treatment: Report
2023年1月23日 · Still many patients on high-dose corticosteroids, report finds. The analysis included data from 962 people with the disease in the U.S., as well as insights from 138 …
Lupkynis helps protect kidneys with lupus nephritis and high...
2023年6月12日 · Lupkynis is approved in the U.S., European Union, and the U.K. as an oral treatment for adults with active lupus nephritis when combined with background …